Plasma PAI-1 levels are elevated in patients with NAFLD, and there is accumulating evidence that PAI-1 plays a causal role in the pathogenesis of this condition16,17. Here, SERPINE1 is linked to metabolic dysfunction-associated steatotic liver disease.